$16M sweet spot round size
Most of their 261 investments are in rounds between $18M and $50M
1996
ReCode Therapeutics raised $50M on September 19, 2023
Investors: Sanofi Ventures, OrbiMed Advisors, Solasta Ventures, Vida Ventures, LLC, Leaps by Bayer, Osage University Partners (OUP) and MPM Capital
Arialys Therapeutics, Inc. raised $58M on September 12, 2023
Investors: Avalon BioVentures, Catalys Pacific and MPM Capital
Crossbow Therapeutics, Inc raised $80M on July 11, 2023
Investors: Polaris Partners and MPM Capital
ReNAgade Therapeutics raised $300M on May 23, 2023
Investors: MPM Capital
NextPoint Therapeutics, Inc. raised $80M on January 10, 2023
Investors: Sanofi Ventures, Catalio Capital Management, Sixty Degree Capital, Leaps by Bayer, The Invus Group and MPM Capital
Photys Therapeutics raised $75M on September 8, 2022
Investors: Heritage Medical Systems, Omega Funds, Longwood Fund, 8VC and MPM Capital
Aktis Oncology raised $84M on August 25, 2022
Investors: Octagon Capital Advisors, NS Investment, Pappas Capital, TCG X, Merck Group, Vida Ventures, LLC and MPM Capital
Orna Therapeutics raised $221M on August 16, 2022
Investors: Merck Group and MPM Capital
CODA Biotherapeutics raised $28M on December 2, 2021
Investors: Pacira Pharmaceuticals, Versant Ventures and MPM Capital
ReCode Therapeutics raised $210M on October 21, 2021
Investors: Sanofi Ventures, NS Investment, -, OrbiMed Advisors, Vida Ventures, LLC, Tekla Capital Management, Osage University Partners (OUP) and MPM Capital